Marinus Pharma (NASDAQ: MRNS) reported Q1 EPS of ($0.52), $0.31 better than the analyst estimate of ($0.83). Revenue for the quarter came in at $14.19 million versus the consensus estimate of $2.28 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.